| Name | 2-methyl-4-(piperazin-1-ylmethyl)-1,3-thiazole |
|---|
| Density | 1.155g/cm3 |
|---|---|
| Boiling Point | 305.505ºC at 760 mmHg |
| Molecular Formula | C9H17Cl2N3S |
| Molecular Weight | 270.22200 |
| Flash Point | 138.565ºC |
| Exact Mass | 269.05200 |
| PSA | 56.40000 |
| LogP | 2.72740 |
| Index of Refraction | 1.567 |
| HS Code | 2934100090 |
|---|
|
~58%
880361-73-9 |
| Literature: Merck Sharp and Dohme Limited; DIRAT, Olivier; ELLIOTT, Jason, Matthew Patent: WO2007/3965 A1, 2007 ; Location in patent: Page/Page column 37 ; WO 2007/003965 A1 |
|
~%
880361-73-9 |
| Literature: WO2009/1021 A1, ; Page/Page column 30-31 ; WO 2009/001021 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |